Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood.

Haslene-Hox, Hanne; Madani, Amina; Berg, Kaja C G; Woie, Kathrine; Salvesen, Helga B; Wiig, Helge; Tenstad, Olav

Haslene-Hox, Hanne; Madani, Amina; Berg, Kaja C G; Woie, Kathrine; Salvesen, Helga B; Wiig, Helge; Tenstad, Olav.

Afiliação

Haslene-Hox H; Department of Biomedicine, University of Bergen, Norway ; Department of Bioprocess Technology, SINTEF Materials and Chemistry, Trondheim, Norway.
Madani A; Department of Biomedicine, University of Bergen, Norway.
Berg KC; Department of Biomedicine, University of Bergen, Norway.
Woie K; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
Salvesen HB; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway ; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Wiig H; Department of Biomedicine, University of Bergen, Norway.
Tenstad O; Department of Biomedicine, University of Bergen, Norway.

BBA Clin ; 2: 18-23, 2014 Dec.

Article em En | MEDLINE | ID: mdl-26673827

Palavras-chave

Biomarker; CA-125; CA-125, cancer antigen 125; EDTA, ethylenediaminetetraacetic acid; FIGO, International Federation of Gynecology and Obstetrics; Ovarian carcinoma; PBS, phosphate buffered saline; TIF, tumor interstitial fluid; Tumor interstitial fluid; Tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BBA Clin Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google